Wegovy Pill Cost: What You'll Actually Pay in 2026

Search "Wegovy pill cost" and you'll find a wide range of numbers, and most of them aren't wrong — they're just describing different situations. A commercially insured patient, a cash-pay patient, and a Medicare patient can each be quoted a completely different monthly price for the exact same bottle of tablets. The confusion usually isn't bad information; it's that nobody specifies which payment path they're talking about.

This guide breaks the Wegovy pill's cost down by every realistic payment path — insured, uninsured, and Medicare — with the exact current numbers for each dose, so you can find the row that actually applies to you.

1. Wegovy Pill Cost: At a Glance

2. List Price vs. What You'll Actually Pay

The Wegovy pill's list price — what's technically called wholesale acquisition cost — runs at an annual rate of roughly $16,413, or a little over $1,368 for a 30-day supply, before any insurance, coupon, or manufacturer discount is applied. Almost nobody actually pays this. It exists mainly as the number insurers use to calculate your deductible progress and as the starting point every discount is subtracted from.

What you actually owe comes down to three questions: do you have commercial insurance that covers Wegovy, are you on Medicare, or are you paying cash? The rest of this guide walks through each answer.

3. Cost With Commercial Insurance

If your employer or marketplace plan is commercial — meaning it isn't Medicare, Medicaid, TRICARE, VA, or another government program — and it covers Wegovy, Novo Nordisk's savings card can bring your copay down to as little as $25 a month.

That "maximum savings" language matters. The card doesn't guarantee a $25 price outright — it covers up to $100 of your copay for a 1-month fill. If your plan's copay for Wegovy is $110, the card brings it down to $10; if your copay is $300, the card only brings it down to $200. Most patients whose plans meaningfully cover Wegovy land close to the $25 floor, but it's worth checking your own plan's copay before assuming the card guarantees the lowest number.

4. Cost Without Insurance (Cash-Pay)

If you don't have insurance that covers Wegovy, or you'd rather not bill insurance at all, Novo Nordisk sells the pill directly through NovoCare Pharmacy at a flat, dose-based cash price — no insurance required, and no eligibility restriction beyond having a valid prescription.

One month is defined as one bottle of 30 tablets. This is the pricing you'll be quoted whether your prescriber sends the prescription electronically to NovoCare Pharmacy for home delivery, or you use it as a reference point while comparing other pharmacies. To see how this stacks up against your local pharmacy or a discount card, run it through a drug price checker before you fill.

5. Full Pricing Table by Dose

6. Medicare and the Wegovy Pill

Medicare coverage for the Wegovy pill runs through two separate channels, and it's worth understanding both so you don't leave savings on the table.

Standard Part D coverage. Medicare Part D plans have been able to cover Wegovy for cardiovascular risk reduction in adults with established heart disease for some time. Since January 1, 2026, Part D plans have also been permitted to cover Wegovy specifically for chronic weight management, though coverage still depends on your individual plan's formulary and any prior authorization it requires.

Medicare GLP-1 Bridge. Separately, Novo Nordisk's federal access agreement lets Medicare patients who prescribed Wegovy for a covered, FDA-approved indication and aren't otherwise covered pay a flat $50 a month, with eligibility determined by CMS, effective July 1, 2026. Importantly, if you're already covered under your standard Part D formulary for an approved use like cardiovascular risk reduction, you generally wouldn't use the Bridge program — you'd work through your plan's normal coverage or its formulary exception process instead. The two paths aren't meant to be combined.

7. Medicaid and the Wegovy Pill

Medicaid coverage of anti-obesity medications, including the Wegovy pill, varies by state — there's no single national answer. Some state Medicaid programs cover GLP-1 medications for weight management, others cover them only for diabetes or cardiovascular indications, and some exclude weight-loss-specific coverage entirely. The commercial savings card cannot be used by Medicaid patients under any circumstances, including if you try to pay cash and skip billing Medicaid.

If you're on Medicaid, the most reliable first step is calling your state Medicaid office or checking your plan's preferred drug list directly, since formulary rules here change more often than commercial insurance rules do.

8. Eligibility for the Savings Card

This eligibility structure is federal law, not a Novo Nordisk policy choice — manufacturer copay cards across the industry are barred from government health program beneficiaries to avoid running afoul of anti-kickback rules. It's one of the most misunderstood parts of GLP-1 pricing, so it's worth confirming your own insurance category before assuming the $25 price applies to you.

9. Income Limits: Is There a Free Option?

Not currently. As of this update, the Wegovy pill is not on NovoCare's income-based charity patient assistance program (PAP) formulary. That's a meaningful difference from some older Novo Nordisk products — Ozempic, for instance, is covered under the PAP for qualifying low-income patients, while Wegovy in either form currently is not.

For context, here's the income structure NovoCare's charity PAP uses for the products it does cover:

If a manufacturer PAP won't help, two nonprofit resources are worth checking: NeedyMeds, a searchable database of assistance programs by drug name, and BenefitsCheckUp, which screens for a broader set of income-based benefits. If you or a Medicare household member also qualify for the Part D low-income subsidy, our Extra Help (LIS) guide explains how that separate program works.

10. What Else NovoCare's Programs Cover

If insulin costs are also part of your household's budget, our insulin price comparison guide and free and $35 insulin guide cover those savings paths in more depth — they run independently of your Wegovy prescription.

11. How to Apply for the Savings Card

12. Approval Timelines

13. Renewal Process

The commercial savings card generally doesn't require a fresh application at every fill — it applies automatically each time you present it with a valid, covered prescription — but Novo Nordisk reserves the right to modify or end the program at any time, so it's worth checking current terms periodically. Insurance prior authorizations typically run 6 to 12 months and require reauthorization showing continued medical need. If your insurance plan changes mid-year, your savings card eligibility and your prior authorization may both need to be re-verified from scratch.

14. Pros and Cons by Payment Path

15. Real Patient Cost Scenarios

Danielle, 34, has employer commercial insurance that covers Wegovy. Her plan's standard copay for the 25 mg dose was $75 a month. After enrolling in the savings card, her cost dropped to $25 — well under the card's $100 maximum, so she gets the full advertised price.

Raj, 41, is self-employed with a high-deductible marketplace plan that doesn't cover weight-management drugs. Rather than paying his plan's full negotiated rate, he uses NovoCare Pharmacy directly and pays $149 a month on the 1.5 mg starting dose, with home delivery.

Carol, 68, is on a Medicare Advantage plan. Her plan doesn't cover Wegovy for weight management yet. Her prescriber's office helped her apply through the Medicare GLP-1 Bridge program, bringing her cost down to $50 a month once CMS eligibility was confirmed — since her government insurance made her ineligible for the commercial $25 savings card.

James, 52, has a commercial plan that technically covers Wegovy but sets a $250 monthly copay. The savings card's $100 maximum still applies, bringing his cost down to $150 rather than the advertised $25 — a reminder that the card reduces your specific copay, it doesn't guarantee a flat price for everyone.

16. Common Mistakes That Inflate Your Cost

• Assuming the $25 price applies to everyone. It's specific to commercially insured patients whose plan already covers Wegovy, capped at $100 in monthly savings.
• Trying to use the savings card with government insurance. This is against the program's terms even if you offer to pay cash and skip billing Medicare or Medicaid.
• Not comparing NovoCare Pharmacy against your local retail pharmacy. Depending on your situation, a discount card like Inside Rx or SingleCare could occasionally beat the manufacturer's flat cash-pay price — it's worth a quick comparison.
• Letting a prior authorization lapse. A missed reauthorization can mean a temporary jump back to full list price at the pharmacy counter until it's renewed.
• Assuming Medicare automatically covers the pill. Coverage depends on your specific Part D plan's formulary — always confirm before filling.
• Not asking about the Medicare GLP-1 Bridge program. Some Medicare patients pay full Part D cost-sharing without realizing a flat $50/month path may be available.
• Waiting for a free patient assistance program that doesn't currently exist for this specific drug, and missing months of treatment in the process.

17. Decision Tree: Which Payment Path Fits You?